# Astrana Health Inc. (ASTH) Investor Outlook: Analyst Ratings Suggest a 45% Upside Potential

- Link: https://www.directorstalkinterviews.com/astrana-health-inc-asth-investor-outlook-analyst-ratings-suggest-a-45-upside-potential/4121243873
- Published: 2026-03-10T11:31:15+00:00
- Author: Madison Wilson

Astrana Health Inc. (ASTH), a key player in the U.S. healthcare sector, is capturing
investor attention with its promising growth potential and analyst ratings indicating
a significant upside. Positioned within the Medical Care Facilities industry, Astrana
Health operates through three main segments: Care Partners, Care Delivery, and Care
Enablement. The company is dedicated to providing comprehensive medical care services,
serving patients across various insurance spectrums, including Medicare and Medicaid,
as well as non-insured individuals.

Currently trading at $24.72, Astrana Health’s stock reflects a slight dip of -0.19(-
0.01%) in recent trading sessions. Despite this minor fluctuation, the stock showcases
a robust 52-week range between $18.16 and $34.05, highlighting its potential for
volatility and opportunity. Significantly, analyst ratings suggest a potential upside
of 45.18%, with a target price range spanning from $26.00 to a notable $50.00. The
average target price of $35.89 further underscores the optimism surrounding Astrana
Health, backed by nine buy ratings and two hold ratings, with no sell ratings to
deter interest.

Astrana Health’s valuation metrics reveal an intriguing picture. While the trailing
P/E ratio is currently unavailable, the forward P/E stands at an attractive 9.47,
suggesting favorable growth expectations aligned with future earnings. This anticipation
is bolstered by an impressive revenue growth rate of 42.90%, indicating the company’s
robust performance in expanding its market presence and operational capabilities.

From a performance perspective, Astrana Health reported an earnings per share (EPS)
of 0.46 and a return on equity (ROE) of 4.49%. While these figures may not position
the company as a high-yield dividend player—given its 0.00% payout ratio and absence
of a dividend yield—they do highlight a strategic focus on reinvesting earnings 
to fuel further growth and expansion.

Astrana Health’s technical indicators provide further insight into its market positioning.
The stock’s 50-day moving average is $23.65, with the 200-day moving average at 
$25.84, suggesting a current market price that is closely aligned with its more 
recent trading patterns. Additionally, the Relative Strength Index (RSI) of 58.54
places the stock within neutral territory, while the MACD reading of 0.64, with 
a signal line of -0.10, indicates a positive momentum trend.

With a market capitalization of $1.24 billion, Astrana Health’s strategic direction
and operational focus paint a compelling picture for investors seeking exposure 
in the healthcare management space. The company’s rebranding from Apollo Medical
Holdings, Inc. to Astrana Health, Inc. in February 2024 marks a new chapter, emphasizing
its commitment to delivering innovative care solutions and expanding its service
offerings.

For individual investors, Astrana Health presents an intriguing opportunity characterized
by strong revenue growth, strategic reinvestment of earnings, and a favorable analyst
outlook. As the company continues to navigate the dynamic healthcare landscape, 
its focus on patient-centered care and diversified service offerings positions it
as a noteworthy contender in the medical care facilities industry.

Share on:
